Market Overview:
The global effusion cells market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for effusion cells in various applications such as sample preparation, thin film growth, molecular beam epitaxy (MBE), surface science analysis, and others. In addition, the growing demand for miniaturized and portable effusion cells is also contributing to the growth of this market.
Product Definition:
A cell that has lost its plasma membrane and releases its contents into the surrounding medium.
Low Temperature Effusion Cells:
Low temperature effusion cells, also known as LTFE or Low Temperature Fluid Effusion is a technology used to remove fluid from a tissue. It's major use is in cryopreservation of sperm and egg cells for later use. The process takes place at temperatures between -196 and -78°C (–80 and –160 °F).
High Temperature Effusion Cells:
High temperature effusion cells (HTC) is a new technology that is used for the treatment of various diseases. It uses a high-temperature environment to kill cancer cells and cure several neurological disorders, such as Parkinson's disease, Alzheimer's disease, and dementia. The main driver of this technology is that it can destroy diseased tissue without affecting healthy tissues.
Application Insights:
The application segment includes sample preparation, thin film growth, molecular beam epitaxy (MBE), surface science analysis and others. The effusion cell market for MBE is anticipated to register the fastest CAGR over the forecast period owing to increasing demand for high-quality wafer Epitaxial Film Growth (EFG) at reduced costs.
Thin film growth emerged as the leading application segment in 2017 and accounted for a revenue share of more than 40% in 2017. Effusion cell usage during EFG process enables rapid prototyping followed by large-scale production of integrated circuits on semiconductor substrates with low cost and high yield. This has led to an increased adoption of effusion cells during EFG processes across various industries such as display & lighting, automotive & transportation among others.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of effusion cell manufacturers and suppliers. The region is expected to maintain its dominance over the forecast period due to increasing R&D investments by various companies. Asia Pacific is expected to grow at a lucrative rate during the forecast period, which can be attributed to increasing healthcare spending in emerging economies such as India and China.
The growth of Latin America region can also be attributed to rising healthcare expenditure coupled with growing patient awareness levels regarding available treatment options for cancerous diseases like effusion cells therapy.
Growth Factors:
- Increasing demand for effusion cells in the research and development sector for drug discovery and development
- Rising prevalence of cancer and other chronic diseases that require effusion cell-based therapies
- Growing number of collaborations between pharmaceutical companies and biotechnology firms to develop novel effusion cell-based therapies
- Technological advancements in effusion cell technology that improve efficiency, accuracy, and reproducibility of results
- increasing investment in the field of oncology by pharmaceutical companies
Scope Of The Report
Report Attributes
Report Details
Report Title
Effusion Cells Market Research Report
By Type
Low Temperature Effusion Cells, High Temperature Effusion Cells
By Application
Sample Preparation, Thin Film Growth, Molecular Beam Epitaxy (MBE), Surface Science Analysis, Others
By Companies
SVT Associates (SVTA), MBE-Komponenten, Riber, Sentys, DCA Instruments, CreaTec Fischer & Co. GmbH, E-Science, UMC Corp, Henniker Scientific, Scienta Omicron, RBD Instruments, Vinci Technologies, Nano4Energy
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Effusion Cells Market Report Segments:
The global Effusion Cells market is segmented on the basis of:
Types
Low Temperature Effusion Cells, High Temperature Effusion Cells
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Sample Preparation, Thin Film Growth, Molecular Beam Epitaxy (MBE), Surface Science Analysis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SVT Associates (SVTA)
- MBE-Komponenten
- Riber
- Sentys
- DCA Instruments
- CreaTec Fischer & Co. GmbH
- E-Science
- UMC Corp
- Henniker Scientific
- Scienta Omicron
- RBD Instruments
- Vinci Technologies
- Nano4Energy
Highlights of The Effusion Cells Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Low Temperature Effusion Cells
- High Temperature Effusion Cells
- By Application:
- Sample Preparation
- Thin Film Growth
- Molecular Beam Epitaxy (MBE)
- Surface Science Analysis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Effusion Cells Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Effusion cells are a type of white blood cell that helps the body fight infection.
Some of the major players in the effusion cells market are SVT Associates (SVTA), MBE-Komponenten, Riber, Sentys, DCA Instruments, CreaTec Fischer & Co. GmbH, E-Science, UMC Corp, Henniker Scientific, Scienta Omicron, RBD Instruments, Vinci Technologies, Nano4Energy.
The effusion cells market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Effusion Cells Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Effusion Cells Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Effusion Cells Market - Supply Chain
4.5. Global Effusion Cells Market Forecast
4.5.1. Effusion Cells Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Effusion Cells Market Size (000 Units) and Y-o-Y Growth
4.5.3. Effusion Cells Market Absolute $ Opportunity
5. Global Effusion Cells Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Effusion Cells Market Size and Volume Forecast by Type
5.3.1. Low Temperature Effusion Cells
5.3.2. High Temperature Effusion Cells
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Effusion Cells Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Effusion Cells Market Size and Volume Forecast by Application
6.3.1. Sample Preparation
6.3.2. Thin Film Growth
6.3.3. Molecular Beam Epitaxy (MBE)
6.3.4. Surface Science Analysis
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Effusion Cells Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Effusion Cells Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Effusion Cells Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Effusion Cells Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Effusion Cells Demand Share Forecast, 2019-2026
9. North America Effusion Cells Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Effusion Cells Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Effusion Cells Market Size and Volume Forecast by Application
9.4.1. Sample Preparation
9.4.2. Thin Film Growth
9.4.3. Molecular Beam Epitaxy (MBE)
9.4.4. Surface Science Analysis
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Effusion Cells Market Size and Volume Forecast by Type
9.7.1. Low Temperature Effusion Cells
9.7.2. High Temperature Effusion Cells
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Effusion Cells Demand Share Forecast, 2019-2026
10. Latin America Effusion Cells Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Effusion Cells Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Effusion Cells Market Size and Volume Forecast by Application
10.4.1. Sample Preparation
10.4.2. Thin Film Growth
10.4.3. Molecular Beam Epitaxy (MBE)
10.4.4. Surface Science Analysis
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Effusion Cells Market Size and Volume Forecast by Type
10.7.1. Low Temperature Effusion Cells
10.7.2. High Temperature Effusion Cells
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Effusion Cells Demand Share Forecast, 2019-2026
11. Europe Effusion Cells Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Effusion Cells Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Effusion Cells Market Size and Volume Forecast by Application
11.4.1. Sample Preparation
11.4.2. Thin Film Growth
11.4.3. Molecular Beam Epitaxy (MBE)
11.4.4. Surface Science Analysis
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Effusion Cells Market Size and Volume Forecast by Type
11.7.1. Low Temperature Effusion Cells
11.7.2. High Temperature Effusion Cells
11.8. Basis Point Share (BPS) Analysis by Type 11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Effusion Cells Demand Share, 2019-2026
12. Asia Pacific Effusion Cells Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Effusion Cells Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Effusion Cells Market Size and Volume Forecast by Application
12.4.1. Sample Preparation
12.4.2. Thin Film Growth
12.4.3. Molecular Beam Epitaxy (MBE)
12.4.4. Surface Science Analysis
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Effusion Cells Market Size and Volume Forecast by Type
12.7.1. Low Temperature Effusion Cells
12.7.2. High Temperature Effusion Cells
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Effusion Cells Demand Share, 2019-2026
13. Middle East & Africa Effusion Cells Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Effusion Cells Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Effusion Cells Market Size and Volume Forecast by Application
13.4.1. Sample Preparation
13.4.2. Thin Film Growth
13.4.3. Molecular Beam Epitaxy (MBE)
13.4.4. Surface Science Analysis
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Effusion Cells Market Size and Volume Forecast by Type
13.7.1. Low Temperature Effusion Cells
13.7.2. High Temperature Effusion Cells
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Effusion Cells Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Effusion Cells Market: Market Share Analysis
14.2. Effusion Cells Distributors and Customers
14.3. Effusion Cells Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. SVT Associates (SVTA)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. MBE-Komponenten
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Riber
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sentys
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. DCA Instruments
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. CreaTec Fischer & Co. GmbH
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. E-Science
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. UMC Corp
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Henniker Scientific
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Scienta Omicron
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. RBD Instruments
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Vinci Technologies
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Nano4Energy
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
